You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A study showed that chromothripsis, a mutational process that can lead to congenital disease and cancer, can result from on-target editing with Cas9.
The lawsuit didn't start as a fight between 10x Genomics and Bio-Rad Laboratories, but it will add another chapter to the long feud between them.
In Nature this week: new single-cell RNA sequencing data preprocessing approach, and more.
Earlier this month, GranatumX, which uses a web-based graphical environment, was approved for the Human Cell Atlas Data Portal's analysis tools registry.
The method, which uses a metabolic marker called hexokinase-2, could be developed to predict cancer patient prognosis and determine progression-free survival.
The University of Washington spinout, formerly called Split Biosciences, has received orders for its new whole-transcriptome kit from 50 early-access partners.
The study uncovered virus-specific as well as shared host factors, including a lysosomal protein that SARS-CoV-2 requires to infect primary lung cells.
SUGAR-seq, a single-cell method developed by researchers in Australia, is a first step towards analyzing differences in glycosylation in various cell types.
The researchers found new molecular pathways of resistance, including hypoxia tolerance, protein folding, and mitochondria respiration.
The single-cell and spatial genomics company is planning a 50 percent increase in headcount, including the addition of 100 people to its commercial organization.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.